157 related articles for article (PubMed ID: 32147297)
21. Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database.
Dodd C; Pacurariu A; Osokogu OU; Weibel D; Ferrajolo C; Vo DH; Becker B; Kors JA; Sturkenboom M
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1249-1256. PubMed ID: 30066460
[TBL] [Abstract][Full Text] [Related]
22. Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy.
Scavone C; Di Mauro C; Brusco S; Bertini M; di Mauro G; Rafaniello C; Sportiello L; Rossi F; Capuano A
Expert Opin Drug Saf; 2019 May; 18(5):427-433. PubMed ID: 30907147
[No Abstract] [Full Text] [Related]
23. Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy).
Tafuri S; Fortunato F; Gallone MS; Stefanizzi P; Calabrese G; Boccalini S; Martinelli D; Prato R
Vaccine; 2018 Feb; 36(8):1072-1077. PubMed ID: 29358055
[TBL] [Abstract][Full Text] [Related]
24. Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience.
Oosterhuis I; Scholl J; van Puijenbroek E; Kant A; van Hunsel F
Drug Saf; 2023 Jan; 46(1):65-75. PubMed ID: 36350465
[TBL] [Abstract][Full Text] [Related]
25. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.
Pahud BA; Williams SE; Dekker CL; Halsey N; Larussa P; Baxter RP; Klein NP; Marchant CD; Sparks RC; Jakob K; Aukes L; Swope S; Barnett E; Lewis P; Berger M; Dreskin SC; Donofrio PD; Sejvar JJ; Slade BA; Gidudu J; Vellozzi C; Edwards KM
Pediatr Infect Dis J; 2013 Feb; 32(2):163-8. PubMed ID: 23334340
[TBL] [Abstract][Full Text] [Related]
26. Adverse events following immunization: real causality and myths.
Principi N; Esposito S
Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
[TBL] [Abstract][Full Text] [Related]
27. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
[TBL] [Abstract][Full Text] [Related]
28. Reference set for performance testing of pediatric vaccine safety signal detection methods and systems.
Brauchli Pernus Y; Nan C; Verstraeten T; Pedenko M; Osokogu OU; Weibel D; Sturkenboom M; Bonhoeffer J;
Vaccine; 2016 Dec; 34(51):6626-6633. PubMed ID: 26496461
[TBL] [Abstract][Full Text] [Related]
29. An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System.
Marwitz K; Jones SC; Kortepeter CM; Dal Pan GJ; Muñoz MA
Drug Saf; 2020 May; 43(5):457-465. PubMed ID: 31981082
[TBL] [Abstract][Full Text] [Related]
30. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
[TBL] [Abstract][Full Text] [Related]
31. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.
Williams SE; Klein NP; Halsey N; Dekker CL; Baxter RP; Marchant CD; LaRussa PS; Sparks RC; Tokars JI; Pahud BA; Aukes L; Jakob K; Coronel S; Choi H; Slade BA; Edwards KM
Vaccine; 2011 Sep; 29(40):6920-7. PubMed ID: 21801776
[TBL] [Abstract][Full Text] [Related]
32. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system.
Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA
Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
34. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG
Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641
[TBL] [Abstract][Full Text] [Related]
35. Risk of Intussusception with Rotavirus Vaccine.
Kalaiselvan V; Thota P; Kumar V; Rathore MS; Thota A; Singh GN
Indian J Pediatr; 2017 Feb; 84(2):97-100. PubMed ID: 27641974
[TBL] [Abstract][Full Text] [Related]
36. An approach to death as an adverse event following immunization.
Gold MS; Balakrishnan MR; Amarasinghe A; MacDonald NE
Vaccine; 2016 Jan; 34(2):212-217. PubMed ID: 26608326
[TBL] [Abstract][Full Text] [Related]
37. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
38. No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.
Carnovale C; Raschi E; Leonardi L; Moretti U; De Ponti F; Gentili M; Pozzi M; Clementi E; Poluzzi E; Radice S
Expert Rev Vaccines; 2018 Apr; 17(4):363-381. PubMed ID: 29452497
[TBL] [Abstract][Full Text] [Related]
39. Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012.
Hibbs BF; Miller E; Shi J; Smith K; Lewis P; Shimabukuro TT
Vaccine; 2018 Jan; 36(4):553-558. PubMed ID: 29248264
[TBL] [Abstract][Full Text] [Related]
40. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
